期刊文献+

分化抑制因子1对结肠癌HT-29细胞增殖的影响 被引量:2

Effect of inhibitor of differentiation-1 on proliferation of colon carcinoma HT-29 cells
下载PDF
导出
摘要 目的探讨检测分化抑制因子1(Id1)对结肠癌HT-29细胞增殖中的影响。方法 HT-29转染Id1表达质粒及合成Id1干扰序列转染HT-29细胞后,RT-PCR和Western blot法检测VEGF mRNA和蛋白的表达,MTT法检测各组细胞增殖情况。结果 Id1过表达能显著上调VEGF mRNA和蛋白表达(P<0.05),促进细胞的生长,Id1抑制后能显著下调VEGF mRNA和蛋白表达(P<0.05),减缓细胞的生长。结论在结肠癌HT-29细胞中Id1为VEGF的上游基因,Id1可通过调控VEGF途径来影响结肠癌细胞增殖,在肿瘤血管生成中发挥重要作用。Id1有望成为结肠癌治疗的一个新靶点。 Objective To investigate the role of inhibitor of differentiation-l(Idl) on proliferation of colon carcinoma HT-29 cells. Methods The expression of VEGF mRNA and protein was detected by RT-PCR and the Western blot assay in HT-29 cells after HT-29 cells transfection with Idl expressing plasmid and Idl-siRNA. The impact on proliferation of HT-29 cells was investi- gated by MTT methods. Results The overexpression of Idl could promote both the mRNA and protein of VEGF and Idl suppres- sion could significantly reduce both the mRNA and protein of VEGF. The MTT assay showed that the cell proliferation of the sup- pression group was significantly slower than that of the control group. Conclusion Suppression of Idl can down regulate the ex- pression of VEGF in HT-29 cells and play an important role in colon carcinoma proliferation. Idl is expected to become a new target for colon cancer therapy.
作者 于游 张才全
出处 《重庆医学》 CAS CSCD 北大核心 2013年第8期848-849,852,共3页 Chongqing medicine
关键词 结肠肿瘤 分化抑制因子1 细胞增殖 colon carcinoma Idl cell protKeration
  • 相关文献

参考文献15

  • 1Ling MT,Wang X,Zhang X,et al.The multiple roles of Id-1 in cancer progression[J].Differentiation,2006,74(9-10):481-487.
  • 2Meteoglu I,Meydan N,Erkus M.Id-1:regulator of EGFR and VEGF and potential target for colorectal cancer therapy[J].J Exp Clin Cancer Res,2008,27:69.
  • 3Langlands K,Down GA,Kealey T.Id proteins are dynamically expressed in normal epidermis and dysregulated in squamous cell carcinoma[J].Cancer Res,2000,60(21):5929-5933.
  • 4Jang TJ,Jung KH,Choi EA.Id-1 gene downregulation by sulindac sulfide and its upregulation during tumor development in gastric cancer[J].Int J Cancer,2006,118(6):1356-1363.
  • 5Schindl M,Oberhuber G,Obermair A,et al.Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer[J].Cancer Res,2001,61(15):5703-5706.
  • 6Takai N,Miyazaki T,Fujisawa K,et al.Id1 expression is associated with histological grade and invasive behavior in endometrial carcinoma[J].Cancer Lett,2001,165(2):185-193.
  • 7Coppe JP,Itahana Y,Moore DH,et al.Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression[J].Clin Cancer Res,2004,10(6):2044-2051.
  • 8Maw MK,Fujimoto J,Tamaya T.Expression of the inhibitor of DNA-binding(id)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers[J].Br J Cancer,2008,99(10):1557-1563.
  • 9Wilson JW,Deed RW,Inoue T,et al.Expression of Id elix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index[J].Cancer Res,2001,61(24):8803-8810.
  • 10曾达武,方明霞,刘豫瑞.RNA干扰分化抑制因子-1基因表达对食管鳞状细胞癌增殖与凋亡的影响[J].福建医科大学学报,2009,43(6):447-451. 被引量:5

二级参考文献11

  • 1刘豫瑞,庄则豪,李友炳,黄雄飞,曾达武.ID-1、Ki-67及Bcl-2在食管鳞状细胞癌中的表达及意义[J].中华消化内镜杂志,2005,22(5):327-330. 被引量:10
  • 2Mariette C, Piessen G,Triboulet J P. Therapeutic strategies in esophageal carcinoma : role of surgery and other modalities[J]. Lancet Oncol , 2007,8(6) :544-553.
  • 3Hui C M,Cheung P Y,Ling M T, etal. Id-1 promotes proliferation of p53-deficient esophageal cancer cells[J]. Int J Cancer, 2006,119(3):508-514.
  • 4Lee T K,Poon R T,Yuen A P, etal. Regulation of angiogenesis by Id-1 through hypoxia-inducible factetor-la-mediated vascular endothelial growth factor up-regulation in hepatoeellular carcinoma[J].Clin Cancer Res , 2006,12(13) :6910-6919.
  • 5Bass B L. RNA intefrerence, the short answer[J]. Nature, 2001,411 (6836) :428-429.
  • 6Davidson B L, Boudreau R L. RNA interference: a tool for querying nervous system function and an emerging herapy[J]. Neuron, 2007 ,53 (6) : 781-788.
  • 7Wesetrhout E M, Berkhout B. A systematic analysis of the effect of target RNA structure on RNA inetfrerence[J]. Nucleic Acids Res, 2007,35 (13):4322-4330.
  • 8Li B,Cheung P Y,Wang X, et al. Id-1 activation of PISK/ Akt/NF-kappa B signaling pathway and its significance in promoting survival of esophageal cancer cells[J]. Carcinogenesis J T- Carcinogenesis, 2007,28(11) ,2313-2320.
  • 9Swarbrick A, Akerfeldt M C, Lee C S, et al. Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix loop helix protein Id-1[J]. Oncogene, 2005, 24(3) :381-389.
  • 10Zhang X M,Ling M T,Wang Q, ct al. Identification of a novel inhibitor of differentiation-1 binding partner, eaveolin-1, and its role in epithelial-mesenchymal transitionand resistance to apoptosis in prostate cancer cells[J].J Boil Chem, 2007, 282(46) :33284-33294.

共引文献4

同被引文献32

  • 1李晓军,秦浚川.细胞分化抑制因子(Id)研究进展[J].生物化学与生物物理进展,2004,31(10):865-869. 被引量:29
  • 2Nouri H,Ben Maitigue M,Abid L,et al.Surface osteosarcoma:Clinical features and therapeutic implications[J].J Bone Oncol,2015,4(4):115-123.
  • 3Friebele JC,Peck J,Pan X,et al.Osteosarcoma:A Meta-analysis and review of the literature[J].Am J Orthop(Belle Mead NJ),2015,44(12):547-553.
  • 4Sharma BK,Kolhe R,Black SM,et al.Inhibitor of differentiation 1transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells[J].FASEB J,2016,30(1):262-275.
  • 5Papaspyridonos M,Matei I,Huang Y,et al.Id1suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation[J].Nat Commun,2015,29(6):6840.
  • 6Beisswenger M,Cabrele C.Self-recognition behavior of a helixloop-helix domain by a fragment scan[J].Biochim Biophys Acta,2014,1844(9):1675-1683.
  • 7Sharma P,Chinaranagari S,Chaudhary J.Inhibitor of differentiation 4(ID4)acts as an inhibitor of ID-1,-2and-3and promotes basic helix loop helix(bHLH)E47 DNA binding and transcriptional activity[J].Biochimie,2015,112:139-150.
  • 8Cheng YJ,Lee YC,Chiu WC,et al.High Id1expression,a generally negative prognostic factor,paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients[J].Oncotarget,2014,5(22):11564-11575.
  • 9Li H,Guo L,Huang A,et al.Nanoparticle-conjugated aptamer targeting hnRNP A2/B1can recognize multiple tumor cells and inhibit their proliferation[J].Biomaterials,2015,63:168-176.
  • 10Li Y,Wagner ER,Yan Z,et al.The calcium-binding protein S100A6accelerates human osteosarcoma growth by promoting cell proliferation and inhibiting osteogenic differentiation[J].Cell Physiol Biochem,2015,37(6):2375-2392.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部